c-Targeted Gene Editing for Cancer Immunotherapy

Pubblicato il 17-11-2026 · Italian Ministry of Education, University and Research · Roma

Università degli Studi di Perugia invites applications for a Research Fellow to advance gene-targeting and genome-editing strategies aimed at selectively modulating conventional type 1 dendritic cells (cDC1) in cancer immunotherapy.

Dato che un elevato numero di candidati potrebbe essere interessato a questa posizione, si assicuri di inviare il suo CV il prima possibile.

The project will cover design of regulatory-region targeting systems, vector engineering, and optimization of AhR targeting in xlwpduy cDC1, with analyses by molecular methods, flow cytometry and gene expression to evaluate efficiency and specificity.
Max. 8 MB. Formati Accettati: PDF, RTF, DOC, DOCX, ODT.